Medical News

The Influence of Docetaxel Schedule on Treatment Tolerabilit...
BMC Cancer

Weekly docetaxel is associated with a lower risk of neutropenia, febrile neutropenia and neuropathy than the three-...

25 Jan 2022

Fibrinogen/Albumin Ratio as A Promising Predictor of Platinu...
BMC Cancer

The FAR might be a potential preoperative biochemical marker for predicting treatment response and oncological...

24 Jan 2022

Serum Cholinesterase May Independently Predict Prognosis in...
BMC Cancer

Baseline ChE may have independent prognostic value for NSCLC patients. Longitudinal studies should be performed to...

24 Jan 2022

The Impact of Hormone Receptor on the Clinical Outcomes of H...
Int. J. Clin. Oncol.

This study revealed profound heterogeneity associated with HR status in the clinical outcomes of HER2-positive...

19 Jan 2022

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Lung Cancer

This slide set provides information on types of lung cancer,epidemiology, pathophysiology, risk factors/causes, clinical features, diagnosis,...

 
Email this page

Key Trials

Interim Analysis of Randomized Phase 3 METEOR Trial – Cabzantinib vs Everolimus in Advanced Renal Cell Carcinoma

The present study reports the final overall survival results from the METEOR study that compared the efficacy and safety of cabozantinib versus...

CELESTIAL: Cabozantinib vs. Placebo increases Overall Survival and Progression-free Survival in Patients with Advanced Hepatocellular Carcinoma

The CELESTIAL trial demonstrated that cabozantinib, compared with placebo improved the survival and progression-free survival in patients with...

CABOSUN Trial: Overall Survival and Progression Free Survival with Cabozantinib versus Sunitinib as Initial Therapy for Metastatic Renal Cell Carcinoma

CABOSUN trial assessed overall survival and progression free survival cabozantinib versus sunitinib as initial targeted therapy in patients with...

EORTC-NCIC Trial: 5-Year Survival Outcomes with Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy Alone in Patients with Glioblastoma

This study presents the 5-year long-term results of EORTC-NCIC trial evaluating survival outcomes with radiotherapy with concomitant and adjuvant...

Patient Education

All You Need to Know About Erlotinib

Erlotinib is a indicated for Lung and Pancreatic cancer. This input describes Erlotinib administration & possible side effects.

All You Wanted to Know About Thyroid Cancer

Thyroid cancer is relatively uncommon compared to other cancers. This input describes the risk factors, symptoms, diagnosis and over all treatment fo...

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding.